US Stock MarketDetailed Quotes

Soleno Therapeutics (SLNO)

Watchlist
  • 52.630
  • +0.120+0.23%
Close Apr 10 16:00 ET
  • 52.630
  • 0.0000.00%
Post 20:01 ET
2.72BMarket Cap134.95P/E (TTM)

Soleno Therapeutics (SLNO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
190.41M
91.73M
66.02M
32.66M
0
0
0
0
0
0
Operating revenue
--190.41M
--91.73M
--66.02M
--32.66M
--0
--0
--0
--0
--0
--0
Cost of revenue
2.7M
863K
1.14M
696K
0
0
0
0
Gross profit
187.71M
90.87M
64.88M
31.96M
0
0
0
0
Operating expense
-6.33%172.76M
-14.21%50.44M
-46.86%42.16M
60.93%37.39M
85.39%42.78M
376.93%184.43M
358.25%58.79M
747.51%79.34M
179.55%23.23M
182.42%23.07M
Selling and administrative expenses
24.81%132.13M
9.58%40.88M
-31.39%33.75M
159.33%28.24M
245.36%29.26M
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
-General and administrative expense
----
----
----
----
245.36%29.26M
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
Research and development costs
-48.29%40.63M
-55.52%9.56M
-72.11%8.41M
-25.89%9.15M
-7.43%13.52M
211.91%78.57M
147.28%21.49M
398.73%30.14M
140.07%12.34M
174.68%14.6M
Operating profit
108.11%14.95M
168.77%40.43M
128.64%22.72M
76.65%-5.42M
-85.39%-42.78M
-376.93%-184.43M
-358.25%-58.79M
-747.51%-79.34M
-179.55%-23.23M
-182.42%-23.07M
Net non-operating interest income expense
-2.92%11.48M
20.64%3.78M
8.68%3.91M
-39.71%1.82M
-5.15%1.97M
358.53%11.82M
46.18%3.13M
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
Non-operating interest income
40.66%16.95M
52.45%5.13M
47.33%5.3M
5.94%3.19M
60.38%3.33M
367.49%12.05M
56.95%3.37M
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
Non-operating interest expense
2,270.56%5.48M
483.98%1.35M
--1.39M
--1.38M
--1.36M
--231K
--231K
--0
--0
--0
Other net income (expense)
-70.76%-5.54M
-161.16%-854K
29.99%-614K
32.74%-1.1M
-639.90%-2.97M
-11.95%-3.24M
46.48%-327K
47.61%-877K
-424.68%-1.64M
-34.11%-401K
Special income (charges)
-70.76%-5.54M
-161.16%-854K
29.99%-614K
32.74%-1.1M
-639.90%-2.97M
-19.45%-3.24M
69.75%-327K
14.10%-877K
-423.00%-1.64M
-34.11%-401K
-Less:Restructuring and merger&acquisition
70.76%5.54M
161.16%854K
-29.99%614K
-32.74%1.1M
639.90%2.97M
19.45%3.24M
-69.75%327K
-14.10%877K
423.00%1.64M
34.11%401K
Income before tax
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Income tax
Net income
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Net income continuous Operations
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Minority interest income
Net income attributable to the parent company
111.88%20.89M
177.45%43.36M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Preferred stock dividends
Other preferred stock dividends
415K
0
Net income attributable to common stockholders
111.64%20.48M
176.71%42.94M
133.95%26.01M
78.46%-4.71M
-104.57%-43.77M
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
Basic earnings per share
109.13%0.4
164.57%0.82
126.78%0.49
84.21%-0.09
-61.02%-0.95
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
32.95%-0.59
Diluted earnings per share
108.90%0.39
162.99%0.8
125.68%0.47
84.21%-0.09
-61.02%-0.95
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
32.95%-0.59
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 190.41M91.73M66.02M32.66M000000
Operating revenue --190.41M--91.73M--66.02M--32.66M--0--0--0--0--0--0
Cost of revenue 2.7M863K1.14M696K0000
Gross profit 187.71M90.87M64.88M31.96M0000
Operating expense -6.33%172.76M-14.21%50.44M-46.86%42.16M60.93%37.39M85.39%42.78M376.93%184.43M358.25%58.79M747.51%79.34M179.55%23.23M182.42%23.07M
Selling and administrative expenses 24.81%132.13M9.58%40.88M-31.39%33.75M159.33%28.24M245.36%29.26M685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M196.85%8.47M
-General and administrative expense ----------------245.36%29.26M685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M196.85%8.47M
Research and development costs -48.29%40.63M-55.52%9.56M-72.11%8.41M-25.89%9.15M-7.43%13.52M211.91%78.57M147.28%21.49M398.73%30.14M140.07%12.34M174.68%14.6M
Operating profit 108.11%14.95M168.77%40.43M128.64%22.72M76.65%-5.42M-85.39%-42.78M-376.93%-184.43M-358.25%-58.79M-747.51%-79.34M-179.55%-23.23M-182.42%-23.07M
Net non-operating interest income expense -2.92%11.48M20.64%3.78M8.68%3.91M-39.71%1.82M-5.15%1.97M358.53%11.82M46.18%3.13M1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M
Non-operating interest income 40.66%16.95M52.45%5.13M47.33%5.3M5.94%3.19M60.38%3.33M367.49%12.05M56.95%3.37M1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M
Non-operating interest expense 2,270.56%5.48M483.98%1.35M--1.39M--1.38M--1.36M--231K--231K--0--0--0
Other net income (expense) -70.76%-5.54M-161.16%-854K29.99%-614K32.74%-1.1M-639.90%-2.97M-11.95%-3.24M46.48%-327K47.61%-877K-424.68%-1.64M-34.11%-401K
Special income (charges) -70.76%-5.54M-161.16%-854K29.99%-614K32.74%-1.1M-639.90%-2.97M-19.45%-3.24M69.75%-327K14.10%-877K-423.00%-1.64M-34.11%-401K
-Less:Restructuring and merger&acquisition 70.76%5.54M161.16%854K-29.99%614K-32.74%1.1M639.90%2.97M19.45%3.24M-69.75%327K-14.10%877K423.00%1.64M34.11%401K
Income before tax 111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Income tax
Net income 111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Net income continuous Operations 111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Minority interest income
Net income attributable to the parent company 111.88%20.89M177.45%43.36M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Preferred stock dividends
Other preferred stock dividends 415K0
Net income attributable to common stockholders 111.64%20.48M176.71%42.94M133.95%26.01M78.46%-4.71M-104.57%-43.77M-351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M
Basic earnings per share 109.13%0.4164.57%0.82126.78%0.4984.21%-0.09-61.02%-0.95-85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.5732.95%-0.59
Diluted earnings per share 108.90%0.39162.99%0.8125.68%0.4784.21%-0.09-61.02%-0.95-85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.5732.95%-0.59
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 12 local time, U.S. Vice President Vance stated that negotiations between the United States and Iran failed to reach an agreement, Show More